Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EML1 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
mRNA | MAP1A | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | DUSP4 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
mRNA | TINF2 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | RP11-192H23.4 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | CMTR1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | PPM1A | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
mRNA | GSG2 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | TMC7 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |